“Novel Pyrido[3,2-d]Pyrimidines as HPK1 Inhibitors for Cancer and Inflammatory/Autoimmune Diseases Therapy”

https://pubmed.ncbi.nlm.nih.gov/38116408

This abstract describes the discovery and potential therapeutic use of novel pyrido[3,2-d]pyrimidines as HPK1 inhibitors for treating cancer and inflammatory and autoimmune diseases.